Infection, inflammation and host carbohydrates: A Glyco-Evasion Hypothesis

Glycobiology

Volumn 22, Issue 8, 2012, Pages 1019-1030

  Kreisman, Lori S C ^a   Cobb, Brian A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycosylation; Immune evasion; Infectious disease; Major histocompatibility complex

Indexed keywords

CARBOHYDRATE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE;

CELL FUNCTION; GLYCOSYLATION; HOST PATHOGEN INTERACTION; HOST SUSCEPTIBILITY; IMMUNE EVASION; INFECTION; INFECTION SENSITIVITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARBOHYDRATES; GLYCOSYLATION; HUMANS; IMMUNE EVASION; INFECTION; INFLAMMATION;

EID: 84863220988     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws070     Document Type: Review

References (130)

1. Abbas AK, Lichtman AH, Pober JS. 2000. Cellular and Molecular Immunology. 4th ed. W.B. Saunder Company, Philadelphia, PA.
2. Abdul-Salam F, Moulana MG, Mansour MH. 2000. Age-related structural modulation of T lymphocyte-associated CD45 isoforms. Mech Ageing Dev. 114:21-35. (Pubitemid 30154165)
3. Anthony RM, Kobayashi T, Wermeling F, Ravetch JV. 2011. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 475:110-113.
4. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. 2008. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 320:373-376. (Pubitemid 351555659)
5. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. 2008. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA. 105:19571-19578.
6. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. 2007. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 25:21-50. (Pubitemid 46697901)
7. 1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin Chim Acta. 294:93-103.
8. Berninsone PM, Hirschberg CB. 2000. Nucleotide sugar transporters of the Golgi apparatus. Curr Opin Struct Biol. 10:542-547.
9. Bond A, Cooke A, Hay FC. 1990. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol. 20:2229-2233. (Pubitemid 20368207)
10. Brockhausen I. 1999. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1473:67-95.
11. Brockhausen I, Schachter H, Stanley P. 2009. O-GalNAc Glycans. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology, 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. p. 115-127.
12. Brown SJ, Miller AM, Cowan PJ, Slavin J, Connell WR, Moore GT, Bell S, Elliott PR, Desmond PV, d'Apice AJ. 2004. Altered immune system glycosylation causes colitis in β1,2-fucosyltransferase transgenic mice. Inflamm Bowel Dis. 10:546-556. (Pubitemid 39276461)
13. Chaffin DO, McKinnon K, Rubens CE. 2002. CpsK of Streptococcus agalactiae exhibits β2,3-sialyltransferase activity in Haemophilus ducreyi. Mol Microbiol. 45:109-122. (Pubitemid 35025937)
14. Chen HL, Li CF, Grigorian A, Tian W, Demetriou M. 2009. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching. J Biol Chem. 284:32454-32461.
15. Chervenak R, Cohen JJ. 1982. Peanut lectin binding as a marker for activated T-lineage lymphocytes. Thymus. 4:61-67. (Pubitemid 12159792)
16. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A, Marth J. 2001. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA. 98:1142-1147. (Pubitemid 32121200)
17. Cobb BA, Kasper DL. 2008. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology. 18:707-718.
18. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell. 117:677-687. (Pubitemid 38692532)
19. Colley KJ. 1997. Golgi localization of glycosyltransferases: More questions than answers. Glycobiology. 7:1-13. (Pubitemid 27091315)
20. Collins BE, Smith BA, Bengtson P, Paulson JC. 2006. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol. 7:199-206. (Pubitemid 43135886)
21. Cooke CL, An HJ, Kim J, Canfield DR, Torres J, Lebrilla CB, Solnick JV. 2009. Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology. 137:1061-1071.
22. Cross GA, Takle GB. 1993. The surface trans-sialidase family of Trypanosoma cruzi. Annu Rev Microbiol. 47:385-411. (Pubitemid 23302939)
23. Cummings RD, Smith DF. 1992. The selectin family of carbohydrate-binding proteins: Structure and importance of carbohydrate ligands for cell adhesion. Bioessays. 14:849-856.
24. Davicino RC, Elicabe RJ, Di Genaro MS, Rabinovich GA. 2011. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms. Int Immunopharmacol. 11:1457-1463.
25. Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5N-glycosylation. Nature. 409:733-739. (Pubitemid 32144520)
26. Earl LA, Baum LG. 2008. CD45 glycosylation controls T-cell life and death. Immunol Cell Biol. 86:608-615.
27. Earl LA, Bi S, Baum LG. 2010. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem. 285:2232-2244.
28. Ellies LG, Sperandio M, Underhill GH, Yousif J, Smith M, Priatel JJ, Kansas GS, Ley K, Marth JD. 2002. Sialyltransferase specificity in selectin ligand formation. Blood. 100:3618-3625. (Pubitemid 35303931)
29. Ellies LG, Tsuboi S, Petryniak B, Lowe JB, Fukuda M, Marth JD. 1998. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 9:881-890. (Pubitemid 29024467)
30. Espy C, Morelle W, Kavian N, Grange P, Goulvestre C, Viallon V, Chereau C, Pagnoux C, Michalski JC, Guillevin L, et al. 2011. Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheum. 63:2105-2115.
31. Ferrero-Garcia MA, Trombetta SE, Sanchez DO, Reglero A, Frasch AC, Parodi AJ. 1993. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins. Eur J Biochem. 213:765-771. (Pubitemid 23125647)
32. Fox KL, Cox AD, Gilbert M, Wakarchuk WW, Li J, Makepeace K, Richards JC, Moxon ER, Hood DW. 2006. Identification of a bifunctional lipopolysaccharide sialyltransferase in Haemophilus influenzae: Incorporation of disialic acid. J Biol Chem. 281:40024-40032. (Pubitemid 46041807)
33. Freeze HH, Ng BG. 2011. Golgi glycosylation and human inherited diseases. Cold Spring Harb Perspect Biol. 3:a005371.
34. Fukuda M. 2002. Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta. 1573:394-405. (Pubitemid 35335450)
35. Fukuda M, Tsuboi S. 1999. Mucin-type O-glycans and leukosialin. Biochim Biophys Acta. 1455:205-217. (Pubitemid 29435989)
36. Galvan M, Murali-Krishna K, Ming LL, Baum L, Ahmed R. 1998. Alterations in cell surface carbohydrates on T cells from virally infected mice can distinguish effector/memory CD8+ T cells from naive cells. J Immunol. 161:641-648. (Pubitemid 28323525)
37. Gilbert M, Watson DC, Cunningham AM, Jennings MP, Young NM, Wakarchuk WW. 1996. Cloning of the lipooligosaccharide α-\2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J Biol Chem. 271:28271-28276. (Pubitemid 26374640)
38. Goodarzi MT, Turner GA. 1995. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clin Chim Acta. 236:161-171.
39. Goodarzi MT, Turner GA. 1998. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: Glycan composition varies with disease. Glycoconj J. 15:469-475. (Pubitemid 28295015)
40. Gravel P, Walzer C, Aubry C, Balant LP, Yersin B, Hochstrasser DF, Guimon J. 1996. New alterations of serum glycoproteins in alcoholic and cirrhoticpatients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun. 220:78-85. (Pubitemid 26106802)
41. Green RS, Stone EL, Tenno M, Lehtonen E, Farquhar MG, Marth JD. 2007. Mammalian N-glycan branching protects against innate immune selfrecognition and inflammation in autoimmune disease pathogenesis. Immunity. 27:308-320. (Pubitemid 47284915)
42. Grewal PK, Boton M, Ramirez K, Collins BE, Saito A, Green RS, Ohtsubo K, Chui D, Marth JD. 2006. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol. 26:4970-4981. (Pubitemid 43959278)
43. Grienke U, Schmidtke M, von GS, Kirchmair J, Liedl KR, Rollinger JM. 2012. Influenza neuraminidase: A druggable target for natural products. Nat Prod Rep. 29:11-36.
44. Hennet T, Chui D, Paulson JC, Marth JD. 1998. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA. 95:4504-4509. (Pubitemid 128620781)
45. Hermiston ML, Xu Z, Weiss A. 2003. CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 21:107-137. (Pubitemid 37174528)
46. Herscovics A. 1999. Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim Biophys Acta. 1473:96-107.
47. Higai K, Miyazaki N, Azuma Y, Matsumoto K. 2006. Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett. 580:6069-6075. (Pubitemid 44666787)
48. Hood DW, Cox AD, Gilbert M, Makepeace K, Walsh S, Deadman ME, Cody A, Martin A, Mansson M, Schweda EK, et al. 2001. Identification of a lipopolysaccharide α-2,3-sialyltransferase from Haemophilus influenzae. Mol Microbiol. 39:341-350. (Pubitemid 32113507)
49. Ishibashi Y, Imai S, Inouye Y, Okano T, Taniguchi A. 2006. Effects of carbocisteine on sialyl-Lewis x expression in an airway carcinoma cell line stimulated with tumor necrosis factor-α. Eur J Pharmacol. 530:223-228. (Pubitemid 43075492)
50. Ishibashi Y, Inouye Y, Okano T, Taniguchi A. 2005. Regulation of sialyl-Lewis x epitope expression by TNF-alpha and EGF in an airway carcinoma cell line. Glycoconj J. 22:53-62. (Pubitemid 40674815)
51. Jackson RJ, Hall DF, Kerr PJ. 1999. Myxoma virus encodes an α2,3-sialyltransferase that enhances virulence. J Virol. 73:2376-2384. (Pubitemid 29098143)
52. Jaeken J. 2010. Congenital disorders of glycosylation. Ann N Y Acad Sci. 1214:190-198.
53. Kaneko Y, Nimmerjahn F, Ravetch JV. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 313:670-673. (Pubitemid 44201145)
54. Kornfeld R, Kornfeld S. 1985. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 54:631-664. (Pubitemid 15073660)
55. Kreisman LS, Cobb BA. 2011. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J Biol Chem. 286:8810-8818.
56. Lee HJ, Lairson LL, Rich JR, Lameignere E, Wakarchuk WW, Withers SG, Strynadka NC. 2011. Structural and kinetic analysis of substrate binding to the sialyltransferase Cst-II from Campylobacter jejuni. J Biol Chem. 286:35922-35932.
57. Leir SH, Parry S, Palmai-Pallag T, Evans J, Morris HR, Dell A, Harris A. 2005. Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. Am J Respir Cell Mol Biol. 32:453-461. (Pubitemid 40629331)
58. Lewis AL, Desa N, Hansen EE, Knirel YA, Gordon JI, Gagneux P, Nizet V, Varki A. 2009. Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure. Proc Natl Acad Sci USA. 106:13552-13557.
59. Linden S, Semino-Mora C, Liu H, Rick J, Dubois A. 2010. Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patients. Helicobacter. 15:251-258.
60. Liu FT, Rabinovich GA. 2010. Galectins: Regulators of acute and chronic inflammation. Ann N Y Acad Sci. 1183:158-182.
61. Lowe JB. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol. 15:531-538. (Pubitemid 37176961)
62. Mackiewicz A, Rose-John S, Schooltink H, Laciak M, Gorny A, Heinrich PC. 1992. Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of α1-protease inhibitor secreted by HepG2 cells. FEBS Lett. 306:257-261.
63. Magalhaes A, Reis CA. 2010. Helicobacter pylori adhesion to gastric epithelial cells is mediated by glycan receptors. Braz J Med Biol Res. 43:611-618.
64. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, et al. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 297:573-578. (Pubitemid 34815336)
65. Mann AC, Record CO, Self CH, Turner GA. 1994. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: Large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta. 227:69-78. (Pubitemid 24227300)
66. Marek KW, Vijay IK, Marth JD. 1999. A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology. 9:1263-1271.
67. Markine-Goriaynoff N, Gillet L, Karlsen OA, Haarr L, Minner F, Pastoret PP, Fukuda M, Vanderplasschen A. 2004. The core 2 β-1,6-N- acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to posttranslational modifications of structural proteins. J Gen Virol. 85:355-367. (Pubitemid 38262570)
68. Martino AT, Mueller C, Braag S, Cruz PE, Campbell-Thompson M, Jin S, Flotte TR. 2011. N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance. Am J Respir Cell Mol Biol. 44:824-830.
69. Matsuzwa M, Ota H, Hayama M, Zhang MX, Sano K, Honda T, Ueno I, Akamatsu T, Nakayama J. 2003. Helicobacter pylori infection up-regulates gland mucous cell-type mucins in gastric pyloric mucosa. Helicobacter. 8:594-600. (Pubitemid 37553433)
70. Mizuguchi S, Inoue K, Iwata T, Nishida T, Izumi N, Tsukioka T, Nishiyama N, Uenishi T, Suehiro S. 2006. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer. Ann Surg Oncol. 13:1010-1018.
71. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S. 2007. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg. 83:216-221. (Pubitemid 44917907)
72. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S. 2007. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer. 58:369-375. (Pubitemid 350051511)
73. Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, Beeton C, Torossian S, Tatarian GG, Lee SU, et al. 2011. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun. 2:334.
74. Moran AP, Gupta A, Joshi L. 2011. Sweet-talk: Role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut. 60:1412-1425.
75. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. 2004. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol. 173:7200-7208. (Pubitemid 39628155)
76. Nanthakumar NN, Dai D, Newburg DS, Walker WA. 2003. The role of indigenous microflora in the development of murine intestinal fucosyl- and sialyltransferases. FASEB J. 17:44-46.
77. Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H. 2011. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: Role of mucosal immune system. Adv Otorhinolaryngol. 72:60-63.
78. Opat AS, van VC, Gleeson PA. 2001. Trafficking and localisation of resident Golgi glycosylation enzymes. Biochimie. 83:763-773.
79. O'Reilly MK, Tian H, Paulson JC. 2011. CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J Immunol. 186:1554-1563.
80. Pacchiarotta T, Hensbergen PJ, Wuhrer M, van NC, Nevedomskaya E, Derks RJ, Schoenmaker B, Koeleman CA, van DJ, Deelder AM, et al. 2012. Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection. J Proteomics. 75:1067-1073.
81. Peyrard M, Seroussi E, Sandberg-Nordqvist AC, Xie YG, Han FY, Fransson I, Collins J, Dunham I, Kost-Alimova M, Imreh S, et al. 1999. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci USA. 96:598-603. (Pubitemid 29061254)
82. Piller F, Piller V, Fox RI, Fukuda M. 1988. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem. 263:15146-15150.
83. Poschet JF, Boucher JC, Tatterson L, Skidmore J, Van Dyke RW, Deretic V. 2001. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc Natl Acad Sci USA. 98:13972-13977. (Pubitemid 33116008)
84. Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, Fukuda M, Varki NM, Marth JD. 2000. The ST3Gal-I sialyltransferasecontrols CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 12:273-283.
85. Rodrigues ML, Dobroff AS, Couceiro JN, Alviano CS, Schauer R, Travassos LR. 2002. Sialylglycoconjugates and sialyltransferase activity in the fungus Cryptococcus neoformans. Glycoconj J. 19:165-173. (Pubitemid 36851259)
86. Roitt IM, Cooke A. 1987. The role of autoantigen in autoimmunity. Immunol Lett. 16:259-263. (Pubitemid 18011303)
87. Roitt IM, Dwek RA, Parekh RB, Rademacher TW, Alavi A, Axford J, Bodman K, Bond A, Cooke A, Hay FC, et al. 1988. Changes in carbohydrate structure of IgG in rheumatoid arthritis. Recenti Prog Med. 79:314-317.
88. Roitt IM, Hutchings PR, Dawe KI, Sumar N, Bodman KB, Cooke A. 1992. The forces driving autoimmune disease. J Autoimmun. 5 Suppl A: 11-26.
89. Rojek JM, Campbell KP, Oldstone MB, Kunz S. 2007. Old World arenavirus infection interferes with the expression of functional α-dystroglycan in the host cell. Mol Biol Cell. 18:4493-4507. (Pubitemid 350060176)
90. Rosen SD. 2004. Ligands for L-selectin: Homing, inflammation, and beyond. Annu Rev Immunol. 22:129-156. (Pubitemid 38680420)
91. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. 2001. Glycosylation and the immune system. Science. 291:2370-2376. (Pubitemid 32231792)
92. Rudd PM, Wormald MR, Stanfield RL, Huang M, Mattsson N, Speir JA, DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA. 1999. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J Mol Biol. 293:351-366. (Pubitemid 29516176)
93. Ryan SO, Bonomo JA, Zhao F, Cobb BA. 2011. MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation. J Exp Med. 208:1041-1053.
94. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, et al. 2007. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 17:1344-1356. (Pubitemid 350131311)
95. Sato S, St-Pierre C, Bhaumik P, Nieminen J. 2009. Galectins in innate immunity: Dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev. 230:172-187.
96. Schachter H. 2000. The joys of HexNAc. The synthesis and function of Nand O-glycan branches. Glycoconj J. 17:465-483. (Pubitemid 32480339)
97. Schauer R. 2009. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol. 19:507-514.
98. Schauer R, Srinivasan GV, Wipfler D, Kniep B, Schwartz-Albiez R. 2011. O-Acetylated sialic acids and their role in immune defense. Adv Exp Med Biol. 705:525-548.
99. Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, Bye PT, Nielson DW, Harry JL, Packer NH, et al. 2007. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology. 17:698-712. (Pubitemid 47050659)
100. Severi E, Hood DW, Thomas GH. 2007. Sialic acid utilization by bacterial pathogens. Microbiology. 153:2817-2822. (Pubitemid 47517045)
101. Shafi R, Iyer SP, Ellies LG, O'Donnell N, Marek KW, Chui D, Hart GW, Marth JD. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA. 97:5735-5739. (Pubitemid 30367467)
102. Stanley P, Guidos CJ. 2009. Regulation of Notch signaling during T- and B-cell development by O-fucose glycans. Immunol Rev. 230:201-215.
103. Stanley P, Okajima T. 2010. Roles of glycosylation in Notch signaling. Curr Top Dev Biol. 92:131-164.
104. Stanley P, Schachter H, Taniguchi N. 2009. N-Glycans. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology, 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. p. 101-114.
105. Stone EL, Ismail MN, Lee SH, Luu Y, Ramirez K, Haslam SM, Ho SB, Dell A, Fukuda M, Marth JD. 2009. Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol. 29:3770-3782.
106. Sujino K, Jackson RJ, Chan NW, Tsuji S, Palcic MM. 2000. A novel viral α2,3-sialyltransferase (v-ST3Gal I): Transfer of sialic acid to fucosylated acceptors. Glycobiology. 10:313-320. (Pubitemid 30145203)
107. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451. (Pubitemid 29504199)
108. Thompson S, Dargan E, Griffiths ID, Kelly CA, Turner GA. 1993. The glycosylation of haptoglobin in rheumatoid arthritis. Clin Chim Acta. 220:107-114. (Pubitemid 23355942)
109. Thompson S, Kelly CA, Griffiths ID, Turner GA. 1989. Abnormally- fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta. 184:251-258. (Pubitemid 19251160)
110. Thon V, Lau K, Yu H, Tran BK, Chen X. 2011. PmST2: A novel Pasteurella multocida glycolipid α2-3-sialyltransferase. Glycobiology. 21:1206-1216.
111. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, et al. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 8:825-834. (Pubitemid 47099035)
112. Tricot G. 2000. New insights into role of microenvironment in multiple myeloma. Lancet. 355:248-250. (Pubitemid 30068513)
113. Troy FA. 1992. Polysialylation: From bacteria to brains. Glycobiology. 2:5-23.
114. Tsuboi S, Fukuda M. 2001. Roles of O-linked oligosaccharides in immune responses. Bioessays. 23:46-53. (Pubitemid 32100500)
115. Turner GA, Goodarzi MT, Thompson S. 1995. Glycosylation of alpha-1- proteinase inhibitor and haptoglobin in ovarian cancer: Evidence for two different mechanisms. Glycoconj J. 12:211-218.
116. Tzianabos AO, Wang JY, Lee JC. 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci USA. 98:9365-9370. (Pubitemid 32743922)
117. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, Hazes JM, Dolhain RJ. 2009. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: Results from a large prospective cohort study. Arthritis Res Ther. 11:R193.
118. van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB. 2004. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol. 287:L944-L952. (Pubitemid 39391024)
119. Varki A. 2011. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology. 21:1121-1124.
120. Vecchi C, Montosi G, Pietrangelo A. 2010. Huh-7: A human "hemochromatotic"cell line. Hepatology. 51:654-659.
121. Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM. 2004. Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev. 68:132-153. (Pubitemid 38339658)
122. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE, Wuhrer M. 2011. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics. 10:M110.
123. Wang Y, Tan J, Sutton-Smith M, Ditto D, Panico M, Campbell RM, Varki NM, Long JM, Jaeken J, Levinson SR, et al. 2001. Modeling human congenital disorder of glycosylation type IIa in the mouse: Conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology. 11:1051-1070. (Pubitemid 34162767)
124. Wesley A, Forstner J, Qureshi R, Mantle M, Forstner G. 1983. Human intestinal mucin in cystic fibrosis. Pediatr Res. 17:65-69. (Pubitemid 13223457)
125. Wieland CW, Koppel EA, den DJ, Florquin S, McKenzie AN, van KY, van der Poll T, Geijtenbeek TB. 2007. Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect. 9:134-141. (Pubitemid 46227998)
126. Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD. 2005. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology. 15:747-775. (Pubitemid 41430096)
127. Yamauchi J, Kawai Y, Yamada M, Uchikawa R, Tegoshi T, Arizono N. 2006. Altered expression of goblet cell- and mucin glycosylation-related genes in the intestinal epithelium during infection with the nematode Nippostrongylus brasiliensis in rat. APMIS. 114:270-278.
128. Ye Z, Marth JD. 2004. N-Glycan branching requirement in neuronal and postnatal viability. Glycobiology. 14:547-558. (Pubitemid 38868269)
129. Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J, Taniguchi N. 2008. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275:1939-1948. (Pubitemid 351569538)
130. Zhu X, Borchers C, Bienstock RJ, Tomer KB. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry. 39:11194-11204.